Trial Profile
A U.S. Retrospective Database Analysis Evaluating the Comparative Effectiveness of Budesonide/Formoterol Combination (BFC) and Fluticasone Propionate/Salmeterol Combination (FSC) Among Asthma Patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 28 Feb 2013
Price :
$35
*
At a glance
- Drugs Budesonide/formoterol (Primary) ; Salmeterol/fluticasone propionate (Primary)
- Indications Asthma
- Focus Therapeutic Use
- Acronyms Asthma CER
- Sponsors AstraZeneca
- 26 Jun 2012 New trial record